Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 10, 2006, Pages 933-935

  Briec, F ^a   Delaire, C ^b   Bouhour, J B ^a   Trochu, J N ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Service de Cardiologie   (France)

Author keywords

Adverse effects; Dilated cardiomyopathy; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; IMIPRAMINE; LITHIUM; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART RATE; HUMAN; RECURRENT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; IMIPRAMINE; MIDDLE AGED; RECURRENCE;

EID: 33846837339     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Luccioni R, Frances Y, Pieri B, et al. Cardiac insufficiency linked to non-IMAO antidepressive agents. Case report. Rev Med Interne 1982;3:193-6.
2. Nizak J, Ledouarin B, Gaudeau S, et al. Myocardiopathies et antidépresseurs tricycliques. A propos de 3 cas. Arch Mal Cœur Vaiss 1983;76:1302-5.
3. Araujo JA, De Freitas FP. Myocardiopathy induced by imipramine. Arq Bras Cardiol 1984;42:209-12.
4. Marti V, Ballester M, Obrador D, et al. Reversal of dilated cardiomyopathy after chronic tricyclic antidepressant drug withdrawal. Int J Cardiol 1995;48:192-4.
5. Roose SP, Glassman AH, Giardina EGV, et al. Nortriptyline in depressed patients with left ventricular impairment. JAMA 1986;256:3253-7.
6. Galetta F, Lunardi M, Cini G, et al. Cardiovascular effects of amitriptyline in therapeutic dosages. Echocardiographic study. Clin Ter 1993;143:29-34.
7. Marti V, Ballester M, Udina C, et al. Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment. Circulation 1995;91:1619-23.
8. Coulter DM, Bate A, Meyboom RH, et al. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ 2001;322:1207-9.